{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:21:52Z","timestamp":1770513712434,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The World Health Organization recommends benzylpenicillin and gentamicin as antimicrobial treatment for infants with sepsis in low-income settings, and ceftriaxone or cefotaxime as an alternative. In a meta-analysis from 13 low-income settings, <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>, <jats:italic toggle=\"yes\">Klebsiella<\/jats:italic> spp. and <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic> accounted for 55% of infants with sepsis. In a review of bacterial meningitis, resistance to third generation cephalosporins was &gt;50% of all isolates, and 44% of Gram-negative isolates were gentamicin resistant. However, ceftriaxone may cause neonatal jaundice, and gentamicin may cause deafness. Therefore, we compared parenteral benzylpenicillin plus gentamicin with ceftriaxone as first-line treatment, assessing outcome and adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was an open randomized trial carried out in the Queen Elizabeth Central Hospital, Blantyre, Malawi, from 2010 to 2013. Infants &lt;60 days of age with possible severe sepsis received either benzylpenicillin and gentamicin or ceftriaxone. Adverse events and outcomes were recorded until 6 months post discharge.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Three-hundred forty-eight infants were included in analyses. Outcome in the benzylpenicillin and gentamicin and ceftriaxone groups was similar; deaths were 13.7% and 16.5% and sequelae were 14.5% and 11.2%, respectively. More infants in the penicillin\/gentamicin group required phototherapy: 15% versus 5%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03. Thirteen (6%) survivors had bilateral hearing loss. There was no difference between the treatment groups. By 6 months post discharge, 11 more infants had died, and 17 more children were found to have sequelae.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Ceftriaxone and gentamicin are safe for infants in our setting. Infants should receive long-term follow-up as many poor outcomes occurred after hospital discharge.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001576","type":"journal-article","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T14:22:19Z","timestamp":1488637339000},"page":"e328-e333","source":"Crossref","is-referenced-by-count":17,"title":["The Treatment of Possible Severe Infection in Infants"],"prefix":"10.1097","volume":"36","author":[{"given":"Elizabeth M.","family":"Molyneux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Queen","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis M.","family":"Banda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Msandeni","family":"Chiume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Singini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macpherson","family":"Mallewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward C.","family":"Schwalbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Heyderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231020","doi-asserted-by":"crossref","first-page":"e1000213","DOI":"10.1371\/journal.pmed.1000213","article-title":"New approaches to preventing, diagnosing, and treating neonatal sepsis.","volume":"7","author":"Edmond","year":"2010","journal-title":"PLoS Med"},{"issue":"10 supp","key":"R3-20231020","first-page":"S17","article-title":"Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group.","volume":"18","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20231020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/archdischild-2012-302033","article-title":"Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO\u2019s currently recommended antibiotics\u2013systematic review and meta-analysis.","volume":"98","author":"Downie","year":"2013","journal-title":"Arch Dis Child"},{"key":"R5-20231020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12879-015-0843-x","article-title":"Burden of bacterial resistance among neonatal infections in low income countries: how convincing is the epidemiological evidence?","volume":"15","author":"Huynh","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R6-20231020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.rmed.2009.03.019","article-title":"Treatment of bacterial meningitis: an overview of Cochrane systematic reviews.","volume":"103","author":"Prasad","year":"2009","journal-title":"Respir Med"},{"key":"R8-20231020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/BF01955067","article-title":"Ceftriaxone\u2013bilirubin-albumin interactions in the neonate: an in vivo study.","volume":"152","author":"Martin","year":"1993","journal-title":"Eur J Pediatr"},{"key":"R9-20231020","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000239361","article-title":"Clinical experience with ceftriaxone treatment in the neonate.","volume":"41","author":"Van Reempts","year":"1995","journal-title":"Chemotherapy"},{"key":"R10-20231020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jac\/19.6.823","article-title":"Bilirubin displacement by ceftriaxone in neonates: evaluation by determination of \u2018free\u2019 bilirubin and erythrocyte-bound bilirubin.","volume":"19","author":"Gulian","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"R11-20231020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00441782","article-title":"Pharmacokinetics and safety of ceftriaxone in the neonate.","volume":"144","author":"Mulhall","year":"1985","journal-title":"Eur J Pediatr"},{"key":"R12-20231020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14740338.7.5.515","article-title":"Safety of ceftriaxone sodium at extremes of age.","volume":"7","author":"Monte","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"R13-20231020","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1542\/peds.2008-3080","article-title":"Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events.","volume":"123","author":"Bradley","year":"2009","journal-title":"Pediatrics"},{"key":"R16-20231020","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM198611273152203","article-title":"Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone.","volume":"315","author":"Laga","year":"1986","journal-title":"N Engl J Med"},{"key":"R17-20231020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/jac\/46.5.653","article-title":"Antibiotics for Salmonella meningitis in children.","volume":"46","author":"Price","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"R18-20231020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/adc.88.5.438","article-title":"Causes and outcome of young infant admissions to a Kenyan district hospital.","volume":"88","author":"English","year":"2003","journal-title":"Arch Dis Child"},{"key":"R19-20231020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0163-4453(05)80003-9","article-title":"Neonatal group B streptococcal infections in Indian (Asian) babies in South Africa.","volume":"22","author":"Haffejee","year":"1991","journal-title":"J Infect"},{"key":"R20-20231020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/02724936.1991.11747472","article-title":"Neonatal meningitis in Harare, Zimbabwe: a 2-year review.","volume":"11","author":"Nathoo","year":"1991","journal-title":"Ann Trop Paediatr"},{"key":"R21-20231020","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/INF.0000000000000210","article-title":"Bacterial meningitis in Malawian infants <2 months of age: etiology and susceptibility to World Health Organization first-line antibiotics.","volume":"33","author":"Swann","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20231020","doi-asserted-by":"crossref","first-page":"e000906","DOI":"10.1136\/bmjopen-2012-000906","article-title":"Bacteraemia in Malawian neonates and young infants 2002\u20132007: a retrospective audit.","volume":"2","author":"Gwee","year":"2012","journal-title":"BMJ Open"},{"key":"R23-20231020","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.arcped.2014.04.033","article-title":"Epidemiology of nosocomial bacterial infection in a neonatal intensive care unit in Morocco.","volume":"21","author":"Maoulainine","year":"2014","journal-title":"Arch Pediatr"},{"key":"R24-20231020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(08)60106-3","article-title":"Clinical signs to predict severe illness in children less than 2 months: a multicentre study.","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"R25-20231020","doi-asserted-by":"crossref","first-page":"e0003979","DOI":"10.1371\/journal.pntd.0003979","article-title":"Modelling the contributions of malaria, HIV, malnutrition and rainfall to the decline in paediatric invasive non-typhoidal Salmonella disease in Malawi.","volume":"9","author":"Feasey","year":"2015","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:16:31Z","timestamp":1697775391000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00020"}},"subtitle":["An Open Randomized Safety Trial of Parenteral Benzylpenicillin and Gentamicin Versus Ceftriaxone in Infants &lt;60 days of Age in Malawi"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001576","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}